Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Predictors of unfavorable perinatal outcomes among women with early-onset preeclampsia without severe features: a retrospective cohort study at Wachemo University Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital

View through CrossRef
Abstract Background Although the prognosis of preeclampsia without severity features is favorable, its adverse forms are a major cause of perinatal and maternal morbidity and mortality. There is no data on predictors and survival time to develop maternal and perinatal unfavorable outcomes of preeclampsia without severity features and normotensive women in the study area. Objective To determine the incidence and predictors of unfavorable perinatal outcomes of early-onset preeclampsia without severity feature and normotensive pregnant women in Wachemo University Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital,2022 G.C. Methods Hospital-based retrospective cohort study was conducted among 132 exposed and 132 unexposed pregnant women at Wachemo University Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital from January 1/2019 to December 30/2021. The incidence of unfavorable perinatal outcomes was calculated from the total adverse outcome to the sample(population) time. Survival probabilities were shown in the Kaplan-Meier graph. Data were entered using the epi data version 4.6 and exported to STATA version 14. Variables having P < 0.25 in bivariate analysis were fitted for multivariate Cox. Results A total of 264 pregnant women were followed for 2305.96 person weeks for perinatal outcomes. The incidence of unfavorable perinatal outcomes was 19.1 per 1000 person-weeks. Gestational age at admission (AHR: 11.81 95%CI:5.94–23.46)), medical illness (AHR: 3.85 95%CI:2.00-7.40), exposure status (AHR:2.64 95%CI:1.20–5.79)) and maternal outcome (AHR: 5.15, 95%CI:2.67–9.92) were predictors of the unfavorable perinatal outcome. Conclusion The Kaplan-Meier survival function graph shows the cumulative survival proportion appears to be much higher in the unexposed group than in the exposed group. There were indicators that were significant for maternal and perinatal outcomes.
Title: Predictors of unfavorable perinatal outcomes among women with early-onset preeclampsia without severe features: a retrospective cohort study at Wachemo University Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital
Description:
Abstract Background Although the prognosis of preeclampsia without severity features is favorable, its adverse forms are a major cause of perinatal and maternal morbidity and mortality.
There is no data on predictors and survival time to develop maternal and perinatal unfavorable outcomes of preeclampsia without severity features and normotensive women in the study area.
Objective To determine the incidence and predictors of unfavorable perinatal outcomes of early-onset preeclampsia without severity feature and normotensive pregnant women in Wachemo University Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital,2022 G.
C.
Methods Hospital-based retrospective cohort study was conducted among 132 exposed and 132 unexposed pregnant women at Wachemo University Nigist Eleni Mohammed Memorial Comprehensive Specialized Hospital from January 1/2019 to December 30/2021.
The incidence of unfavorable perinatal outcomes was calculated from the total adverse outcome to the sample(population) time.
Survival probabilities were shown in the Kaplan-Meier graph.
Data were entered using the epi data version 4.
6 and exported to STATA version 14.
Variables having P < 0.
25 in bivariate analysis were fitted for multivariate Cox.
Results A total of 264 pregnant women were followed for 2305.
96 person weeks for perinatal outcomes.
The incidence of unfavorable perinatal outcomes was 19.
1 per 1000 person-weeks.
Gestational age at admission (AHR: 11.
81 95%CI:5.
94–23.
46)), medical illness (AHR: 3.
85 95%CI:2.
00-7.
40), exposure status (AHR:2.
64 95%CI:1.
20–5.
79)) and maternal outcome (AHR: 5.
15, 95%CI:2.
67–9.
92) were predictors of the unfavorable perinatal outcome.
Conclusion The Kaplan-Meier survival function graph shows the cumulative survival proportion appears to be much higher in the unexposed group than in the exposed group.
There were indicators that were significant for maternal and perinatal outcomes.

Related Results

Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
<p>Preeclampsia is a hypertensive disorder of pregnancy that is diagnosed after the 20th week of gestation. It is defined by the American College of Obstetrics and Gynecology...
Women in Australian Politics: Maintaining the Rage against the Political Machine
Women in Australian Politics: Maintaining the Rage against the Political Machine
Women in federal politics are under-represented today and always have been. At no time in the history of the federal parliament have women achieved equal representation with men. T...
Pregnant Prisoners in Shackles
Pregnant Prisoners in Shackles
Photo by niu niu on Unsplash ABSTRACT Shackling prisoners has been implemented as standard procedure when transporting prisoners in labor and during childbirth. This procedure ensu...
Serum catestatin level in preeclampsia
Serum catestatin level in preeclampsia
Background/Aim: Preeclampsia, a significant cause of maternal morbidity and mortality, is linked to increased cardiovascular risks. Catestatin regulates cardiovascular function whi...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract Introduction Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...

Back to Top